{"schema_version":"1","generated_at":"2026-11-01T01:17:40.027Z","data_as_of":null,"url":"https://www.findmykol.com/kol/moazzam-shahzad","json_url":"https://www.findmykol.com/kol/moazzam-shahzad/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"moazzam-shahzad","name":"Moazzam Shahzad","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of South Florida","institution_url":"https://www.findmykol.com/institution/university-of-south-florida","city":"Tampa","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1932653375","orcid":"0000-0002-9609-6160","openalex":"A5091688355"},"summary":"Moazzam Shahzad is an Oncology physician affiliated with University of South Florida. OpenAlex indexes 411 publications with 796 citations (h-index 13).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":411,"cited_by_count":796,"h_index":13,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":11,"program_years":{"first":2021,"last":null},"rows_total":15,"shown":3,"withheld":12,"rows":[{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":43.32,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932653375"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":135.94,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932653375"},{"payer":"RECORDATI_RARE_DISEASES_INC.","program_year":2024,"amount_usd":107.36,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932653375"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1932653375","source":"payments"},"prescribing":{"data_year":2020,"areas_total":2,"areas_shown":2,"areas":[{"area":"Anti-infectives","share_pct":50,"classes_total":1,"classes":[{"class":"Cephalosporin Antibacterial","setting":"prescribed","share_pct":50,"drugs":[{"name":"Cefdinir","share_pct":100}],"max_beneficiaries":16}]},{"area":"Metabolism & gastrointestinal","share_pct":50,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":50,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"facility","data_year":2020,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged 70 Years and Older: A Systematic Review and Meta-Analysis","year":2025,"journal":"Biology of Blood and Marrow Transplantation","source_url":"https://doi.org/10.1016/j.jtct.2024.12.022","status":"verified"},{"title":"Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/j.clml.2024.12.018","status":"verified"},{"title":"Exploring thermal and entropic behaviors in nanofluid stagnation point flow with nonlinear dynamics","year":2025,"journal":"Case Studies in Thermal Engineering","source_url":"https://doi.org/10.1016/j.csite.2025.106163","status":"verified"},{"title":"Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma","year":2025,"journal":"Future Oncology","source_url":"https://doi.org/10.1080/14796694.2025.2498842","status":"verified"},{"title":"Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/j.clml.2025.08.011","status":"verified"}],"source":"works"},"contact":{"address_1":"12902 USF MAGNOLIA DR","city":"Tampa","state":"FL","zip":"336129416","phone":"813-745-7365","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1932653375","source":"identity"},"similar":[{"name":"Richard Lockey","slug":"richard-lockey","institution":"University of South Florida","specialty":"Allergy & Immunology","url":"https://www.findmykol.com/kol/richard-lockey","json_url":"https://www.findmykol.com/kol/richard-lockey/profile.json"},{"name":"Robert Hauser","slug":"robert-hauser","institution":"University of South Florida","specialty":"Neurology","url":"https://www.findmykol.com/kol/robert-hauser","json_url":"https://www.findmykol.com/kol/robert-hauser/profile.json"},{"name":"Selim Benbadis","slug":"selim-benbadis","institution":"University of South Florida","specialty":"Neurology","url":"https://www.findmykol.com/kol/selim-benbadis","json_url":"https://www.findmykol.com/kol/selim-benbadis/profile.json"},{"name":"Pedram Hamrah","slug":"pedram-hamrah","institution":"University of South Florida","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/pedram-hamrah","json_url":"https://www.findmykol.com/kol/pedram-hamrah/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":12,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-08-13","provider_certified":"2025-08-13","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}